Influenza: statins may help, but did aspirin misuse hinder in 1918?
Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.
Archives for November 2, 2009
Lonza cuts 2009 guidance 14% and plans workforce cuts
Lonza cuts 2009 earning guidance and may reduce its workforce under “Project Bond” cost cutting plan after a Q3 characterized by an “accumulation of unexpected events”
O’Hara launches 3-in-1 coating
O’Hara Technologies has launched a lab-scale tablet coating system that incorporates a blender and tray dry oven inserts to cut capital expense and GMP spaced needed perform these tasks.
Phase Forward plans bright 2010
In Q3 Phase Forward’s revenues from CROs grew by 44 per cent year-on-year and it predicts a bright 2010, as a backlog of delayed trials are started and big pharma attempts to cut IT costs.
MDS’ Central Labs becomes Clearstone Central Laboratories
MDS’ Central Labs has been rebranded as Clearstone Central Laboratories following its acquisition by Czura Thornton, which is looking to expand the business and that of Chiltern, a CRO also owned by the investment company, into new geographies, according...
Efficacy at Ph III: lupus drug Benlysta confirms blockbuster potential
Good news for Human Genome Sciences (HGS) as development partner GSK reports Ph III data showing that their co-owned lupus treatment Benlysta (belimumab) is effective.
Appointments at Synteract, Quintiles, Quanticate and ClinOps – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Synteract, Quintiles, Quanticate and ClinOps.